Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study (2013)
- Authors:
- USP affiliated authors: MESSIAS, ANDRÉ MÁRCIO VIEIRA - FMRP ; JORGE, RODRIGO - FMRP
- Unidade: FMRP
- Subjects: EDEMA MACULAR CISTOIDE; DOENÇAS RETINIANAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Abstracts
- Conference titles: Annual Meeting of Association for Research in Vision and Ophthalmology (ARVO)
-
ABNT
NEPOMUCENO, A. et al. Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study. 2013, Anais.. Seattle: ARVO, 2013. . Acesso em: 19 abr. 2024. -
APA
Nepomuceno, A., Almeida, F. P., Messias, A. M. V., Takaki, É., Ribeiro, J. A. S., Cardillo, J. A., et al. (2013). Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study. In Abstracts. Seattle: ARVO. -
NLM
Nepomuceno A, Almeida FP, Messias AMV, Takaki É, Ribeiro JAS, Cardillo JA, Scott IU, Jorge R. Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study. Abstracts. 2013 ;[citado 2024 abr. 19 ] -
Vancouver
Nepomuceno A, Almeida FP, Messias AMV, Takaki É, Ribeiro JAS, Cardillo JA, Scott IU, Jorge R. Diabetic macular edema treatment with bevacizumab vs. ranibizumab: a microperimetry study. Abstracts. 2013 ;[citado 2024 abr. 19 ] - Ranibizumabe intravítreo no pré-operatório de vitrectomia em pacientes diabéticos com descolamento de retina tracional
- Intravitreal bevacizumab or triamcinolone combined with macular laser photocoagulation for diabetic macular edema: preliminary results
- Intravitreal ranibizumab for persistent new vessels in diabetic retinopathy
- Quality of life in patients with retinitis pigmentosa undergoing treatment with intravitreal bone marrow-derived stem cells (Reticell -clinical trial)
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
- Changes in retinal function and structure following intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment for diabetic macular edema
- Intravitreal autologous bone marrow derived stem cells in ischemic macular edema: results after 6 months follow-up
- Intravitreal injection versus sub-tenon S infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema
- ERG findings after one year intravitreal ranibizumab and single or multiple spot panphotocoagulation treatment for proliferative diabetic retinopathy
- Multifocal ERG before and after pars plana vitrectomy in ILM peeling: one year follow-up
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
